Valentina L. Kouznetsova

SEP 8, 2026 · JOURNAL ARTICLE

An AI-Assisted Workflow for Rapid Prioritization of FDA-Approved Drugs as HDAC3 Inhibitor Candidates for Drug Repurposing

Biology

This is an exploratory computational study using machine learning to predict HDAC3 inhibition by FDA-approved drugs, without experimental validation or clinical data, raising mechanistic questions rather than answering therapeutic ones.